Private Equity

Dealmaking

People

Private Equity Jobs of the Week: Brookfield, Z Capital and Arrowroot are hiring

This week’s jobs include a director spot at Z Capital, a VP at Arrowroot and associate at Brookfield.

2 min read · 28 March 2022

TPG takes advantage of high valuations; KKR’s State of Play a must-read for dealmakers

TPG’s earnings report, out this morning, underscores that it’s a good time for exits; KKR’s recent State of Play report by partner Henry McVey is loaded with analysis.

4 min read · 28 March 2022

Deals

How Impossible vs Motif lawsuit could influence plant-based opportunities

Impossible Foods’ lawsuit alleging patent infringement by Motif is being closely watched by investors. Impossible's backers include Coatue Management, GV and Khosla Ventures, while Motif's investors include BlackRock, General Atlantic and Ontario Teachers' Pension Plan.

3 min read · 28 March 2022

Beware: cracks appearing on the deal front

Is stress, or even distress, inevitable for portfolios? Here’s what to look for – and how to change course before it’s too late.

4 min read · 25 March 2022

AlbaCore prices fourth CLO

European credit investor AlbaCore Capital Group has priced its fourth collateralized loan obligation at 452.2 million euros.

2 min read · 25 March 2022

Spotlight on Thoma Bravo’s Circle CVI deal; vote of confidence for Vista

Thoma Bravo's investment in Circle Cardiovascular Imaging goes under the microscope.

4 min read · 25 March 2022

Featured

Healthcare deal spotlight: Thoma Bravo views Circle CVI as a 'category leader'

'Sometimes it can be hard to find category leaders at a smaller scale, but when you find one, it is really special,' says Thoma Bravo's Carl Press.

5 min read · 24 March 2022

RSM identifies trends to watch; packaging deals heat up; updates on FTV and Knox Lane

FTV and Knox Lane wrap up funds.

5 min read · 24 March 2022

Featured

Why Clearlake and other PE firms are investing in packaging providers

Clearlake is acquiring Intertape Polymer Group, a Montreal packaging company, for $2.6bn in a take-private deal announced earlier this month.

3 min read · 23 March 2022

InTandem and the creation of its Vivo Infusion platform, Iconiq is back with its next growth flagship

Iconiq goes back to market with a new fund.

2 min read · 23 March 2022

Showing 6,601 to 6,610 of 42,643 results
1…660662…1000